Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in Beijing
Bruker Companies Announce the Opening of a Modern Chinese Applications, Demonstration and Customer Training Center in BeijingBEIJING--(BUSINESS WIRE)--Oct. 18, 2007--During the BCEIA 2007 conference, Bruker BioSciences Corp. and the Bruker BioSpin group of companies today announced the official opening of their new Beijing modern applications, demonstration and customer training laboratory, showcasing a wide selection of novel life science and materials (...)
Bruker Daltonics Introduces Several Important and Novel Proteomics Capabilities and Solutions at HUPO 2007
SEOUL, South Korea, Oct 07, 2007 (BUSINESS WIRE) -- At the Human Proteome Organisation's (HUPO) 6th Annual World Congress, Bruker Daltonics is announcing several novel capabilities and solutions for proteomics mass spectrometry at two Bruker luncheon seminars on Monday and Wednesday, as well as in more than 40 scientific oral and poster contributions.
Bruker Daltonics was the first company to introduce ETD (Electron Transfer Dissociation) on its (...)
Bruker BioSciences to Present at UBS Global Life Sciences Conference
Live Webcast on September 26th at 9:00 AM Eastern Time from New York
BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 24, 2007--Bruker BioSciences Corporation today announces that it will join other leading healthcare and life sciences companies in presenting at the UBS Global Life Sciences Conference taking place in New York. The Company will present an update on recent developments and expectations.
The presentation will be webcast live at 9:00 AM Eastern (...)
Bruker Daltonics Announces Contract Award for Phase III of the ARFCAM Program by the U.S. Department of Homeland Security
BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 14, 2007--Bruker Daltonics today announces that it has been awarded a $1.3 million follow-on Phase III contract for further research, development and testing within the Autonomous Rapid Facility Chemical Agent Monitor (ARFCAM) program by the U.S. Department of Homeland Security (DHS). This Phase III program is expected to last about three years during which time Bruker will continue to even further improve its (...)
Bruker BioSciences to Present at Bear Stearns 20th Annual Healthcare Conference
Live Webcast on September 10th at 9:30 AM Eastern Time from New York
BILLERICA, Mass.--(BUSINESS WIRE)--Sept. 7, 2007--Bruker BioSciences Corporation today announces that it will join other leading healthcare and life sciences companies in presenting at the Bear Stearns 20th Annual Healthcare Conference taking place September 10th and 11th in New York. Bruker BioSciences President and CEO Frank Laukien will present an overview of the Company, including (...)
Bruker Daltonics Announces Selection of its Range of Chemical Agent Detectors for Slovenian Armored Vehicles
LEIPZIG, Germany--(BUSINESS WIRE)--Aug. 23, 2007--
Bruker Daltonik GmbH today announced that it was awarded a $3.5 million contract to supply the Slovenian Army with a series of long range and point chemical detectors for integration into Slovenia's new lightweight reconnaissance vehicles. This contract has been awarded in cooperation with Em.tronic d.o.o., a Slovenian defense contractor. The Bruker Daltonics equipment to be supplied consists of (...)
Bruker BioSciences Reports Strong Revenue and Net Income Growth in the Second Quarter of 2007
BILLERICA, Mass.--(BUSINESS WIRE)--July 31, 2007--
Bruker BioSciences Corporation (NASDAQ: BRKR) today reported financial results for the three and six months ended June 30, 2007.
For the second quarter of 2007, revenue increased by 21% to $121.7 million, compared to revenue of $100.5 million in the second quarter of 2006. Excluding the effects of foreign currency translation, second quarter 2007 revenue increased by 17% year-over-year. Net income in (...)
Bruker BioSciences Corporation to Release Second Quarter 2007 Financial Results on July 31, 2007
BILLERICA, Mass.--(BUSINESS WIRE)--July 25, 2007--
Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its second quarter 2007 financial results on Tuesday, July 31, 2007 before the market opens. Bruker BioSciences will then host an operator-assisted earnings conference call that morning at 9 a.m. Eastern Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live web broadcast symbol. The webcast will (...)
Bruker Daltonics Launches Unique ImagePrep(TM) Matrix Deposition Device for MALDI Molecular Imaging in Biomarker Discovery, Drug Imaging and Pathology Research
INDIANAPOLIS--(BUSINESS WIRE)--June 3, 2007--At the 55th ASMS Conference on Mass Spectrometry, Bruker Daltonics today launches its ImagePrep sample preparation device for automated matrix deposition onto tissue slices. MALDI mass imaging of tissue samples with Bruker's MALDI Molecular Imager (for research use only) solution allows color-coded visualization of the distribution of peptide or small protein biomarkers, or of drugs and their major metabolites (...)
Bruker Daltonics Introduces Unique TargetAnalysis(TM) Solution for Multi-target Screening in Forensics, Environmental Testing and Food Analysis
INDIANAPOLIS, Jun 03, 2007 (BUSINESS WIRE) -- At the 55th ASMS Conference on Mass Spectrometry, Bruker Daltonics today announces the launch of its novel TargetAnalysis(TM) application software for multi-target compound screening in complex matrices, providing much increased specificity and enhanced SigmaFit(TM) molecular formula determination.
TargetAnalysis is a library-based screening software solution able to screen hundreds of compounds from a (...)
